<DOC>
	<DOCNO>NCT02592330</DOCNO>
	<brief_summary>The main aim study determine safety feasibility cultivate autologous limbal epithelial cell ( CALEC ) transplantation treatment limbal stem cell deficiency .</brief_summary>
	<brief_title>Safety Feasibility CALEC LSCD</brief_title>
	<detailed_description>This open label , single center study assess safety , feasibility , efficacy Cultivated Autologous Limbal Epithelial Cell ( CALEC ) graft 24 patient unilateral limbal stem cell deficiency . The first 3 participant enrol receive study treatment , CALEC , assess safety feasibility . Subjects 4-24 randomize either study treatment , CALEC , standard treatment LSCD , conjunctival limbal autograft ( CLAU ) 2:1 ratio . Participants receive study intervention corneal biopsy non-diseased eye , provide cell creation CALEC graft . The CALEC make Good Manufacturing Practice ( GMP ) Laboratory , Dana Farber Cancer Institute transport Mass . Eye Ear Infirmary application participant 's diseased eye standard corneal reconstruction procedure . Subjects randomized standard treatment arm undergo CLAU surgery , biopsy perform time surgery . Investigators , study personnel , subject aware study assignment , give different procedure require , surgery . Subjects monitor month 24 ass delay adverse event product ( CALEC ) procedure well assessment durability transplant .</detailed_description>
	<criteria>Male Female patient age 18 80 year old Ability subject guardian/legal representative provide write informed consent comply study assessment full duration study . Patients unilateral limbal stem cell deficiency ( LSCD ) determine conjunctivalization cornea define fibrovascular pannus 2 mm limbus great equal 6 clock hour . Additional optional criterion : Lack limbal palisade Vogt great equal 9 clock hour Goblet cell presence define impression cytologic criterion Corneal ocular surface infection within 30 day prior study entry CALEC transplantation Ocular surface malignancy Uncontrolled diabetes recent HgA1c great 8.5 % Renal Failure eGFR 60 mL/min per 1.73 m2 Aspartate aminotransferase alanine aminotransferase level great 3 time institutional upper limit normal Total bilirubin great 2 time institutional upper limit normal ( except patient know Gilbert 's syndrome ) Platelet level less 100,000 great 450,000 per microliter Hemoglobin level less 11.0 g/dL men le 10.0 g/dL woman Prothrombin time great 16 second activate partial thromboplastin time great 35 second patient take warfarin international normalize ratio great 3 patient take warfarin Inability tolerate monitor anesthesia HIV infection AIDS Hepatitis B C Pregnancy ( positive test ) lactation Participation another simultaneous medical investigation trial Severe cicatricial eye disease Severe dry eye disease determine Schirmer 's test le 1mm least one eye . Any medical , psychiatric , debilitate disease/disorder social condition judgment investigator would interfere serve contraindication adherence study protocol ability give inform consent . Signs current infection , include fever current treatment antibiotic . History allolimbal transplantation Presence allergy CALEC graft chemical component within formulation . Exclusion Based Donor Eye : Conjunctivalization cornea define fibrovascular pannus 2 mm limbus great equal 3 clock hour Lack limbal palisade Vogt great equal 3 clock hour History allolimbal transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>CALEC</keyword>
	<keyword>Limbal Stem Cell Deficiency</keyword>
	<keyword>LSCD</keyword>
</DOC>